Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 23, 2010
Determination of GDC-0449, a small-molecule inhibitor of the Hedgehog signaling pathway, in human plasma by solid phase extraction-liquid chromatographic-tandem mass spectrometryX Ding, B Chou, R A Graham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancerRoy S Herbst, S Gail Eckhardt, Razelle Kurzrock, et al.
Molecular Pharmaceutics|September 19, 2013
Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical developmentGillian S Smelick, Timothy P Heffron, Laura Chu, et al.
Journal of the American College of Emergency Physicians Open|January 15, 2026
Understanding and Addressing Bias in Artificial Intelligence Systems: A Primer for the Emergency Medicine PhysicianEthan E Abbott, Tehreem Rehman, Anthony Rosania, et al.
Cell Death & Disease|August 12, 2016
Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkeyChristina L Zuch de Zafra, Avi Ashkenazi, Walter C Darbonne, et al.
Transplantation|July 9, 2016
Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney TransplantationJoanna M Schaenman, Yael Korin, Tiffany Sidwell, et al.
Anti-Cancer Drugs|August 24, 2013
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxelJavier Cortés, Sandra M Swain, Iveta Kudaba, et al.
Transplantation Proceedings|November 20, 2023
Physical Frailty Predicts Outcomes in Patients Undergoing Evaluation for Kidney TransplantationJoanna Schaenman, Richard Ahn, Christine Lee, et al.
Journal of Onco-Nephrology|February 18, 2026
Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United StatesSamhita Boppana, Christopher D Blosser, Allison B Webber, et al.
Transplantation|August 17, 2022
Apheresis of Deceased Donors as a New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant ToleranceRebecca A Sosa, Thomas Mone, Bita V Naini, et al.
Pageof 17